money received from the IPO after deducting the actual expenses 4. Acquisition of all ordinary shares of Modern Pharma Company Limited, "Modern Company", which is a transaction concerning asset
Committee, Appointment of Audit Committee, Appointment of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27
Allotment of Shares in Excess of Underwriting Amount (No. 2)
Re: Allotment of Shares in Excess of Underwriting Amount
Distribution of Newly Issued Shares and Share Warrants by Issuer
Granting the Purchasing Right to Provider of Over-Allotment Shares After Allotment of Shares in Excess of Underwriting Amount
Provisions relating to Offer for Sale of Shares Issued by Foreign Company Whose Shares Are Not Traded on Foreign Exchange
Granting the Purchasing Right to Provider of Over-Allotment Shares After Allotment of Shares in Excess of Underwriting Amount
) - Translation - Ref. WINNER 0009/2018 February 28, 2018 Re Information Memorandum on Acquiring of Ordinary Shares in Aesthetic Zecret (At-Ze) Co., Ltd. (Additional info.2) To The President The Stock Exchange of
Ref. WINNER 0009/20108 Page 1 of 8 - Translation - Ref. WINNER 0009/2018 February 28, 2018 Re Information Memorandum on Acquiring of Ordinary Shares in Aesthetic Zecret (At-Ze) Co., Ltd. To The